Development and Characterization of Lurasidone Hydrochloride Intranasal Nanoparticulate Drug Delivery System for Brain Delivery
Loading...
Date
item.page.authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Lurasidone hydrochloride (LH) suffers from poor aqueous solubility and low oral
newlinebioavailability which warrants increase of LH doses causing toxicity to normal tissues.
newlineTherefore, the current research focused on curtailing the inherent issues of LH by formulating
newlineits nanoparticles (NPs) and their conjugation via transferrin (Tf). Chitosan (CH)-NPs were
newlineprepared via ionic gelation technique and then optimized using QbD approach. The optimized
newlineNPs were further to Tf conjugation via thiolation technique and further prepared using ionic
newlinegelation method. The prepared NPs were analyzed for in vitro drug release and in vivo brain
newlinetargeting efficiency.
newlineChitosan NPs and Tf-conjugated CH-NPs exhibited mean particle size (154.8±4.5 nm; 207.1±
newline5.43 nm), mean polydispersity index (0.433± 34.5; 0.411 ± 0.065); % EE (88.5± 0.05; 87.6 ±
newline0.06); and % DLC (8.8±0.07; 7.6 ± 0.054) respectively. Transmission electron microscopy
newlineexaminations revealed spherical particle size with uniform drug distribution. Physicochemical
newlinestability of CH-NPs conducted for 12 weeks and showed good stability at (25 ± 2 °C/60 ± 5%
newlineRH). DSC thermogram indicated the complete dispersion of drug within the nanoparticles
newlineattributable to the loss of crystallinity of LH. FTIR spectra of NPs showed existence of Tf at
newlineNPs surface confirming the conjugation of Tf. CH-NPs and Tf-conjugated NPs of LH showed
newlineabsence of drug characteristics diffraction peaks indicating loss of crystallinity due to
newlineentrapment of drug within the NPs. In vitro release studies established supremacy of LH-CHNPs
newlineand Tf-conjugated CH-NPs compared to drug suspension (LH-DS) with cumulative drug
newlinerelease of 85.83% and 89.34 ± 5.65 at pH 7.4 and 89.93±3.78% and 91.93 ± 5.67 at pH 6.4
newlinerespectively. Ex vivo nasal permeation studies revealed a 2.5-fold and 2.7-fold higher nasal
newlinepermeation of LH from CH-NPs and Tf-conjugated CH-NPs formulation respectively
newlinecompared to DS. Confocal microscopy evinced deeper permeation of Tf-conjugated CH-NPs
newline(25 and#956;m), and CH-NPs (20 and#956;m) through nasal mucosa in contrast